MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxias(SCA)"

  • 2025 International Congress

    SCA27B, an Elusive Diagnosis with Effective Symptomatic Treatment: Two Cases of Late-Onset Progressive and Episodic Cerebellar Ataxia

    J. Yomtoob, L. Morse, I. Keller Sarmiento, L. Kinsley, P. Opal, N. Mencacci (Chicago, USA)

    Objective: We present two cases of late-onset progressive and episodic cerebellar ataxia with prolonged courses of complex diagnostic work-up and management prior to genetic Spinocerebellar…
  • 2025 International Congress

    The FGF14-SCA27B GAA•TTC Repeat Shows Marked Somatic Expansion in the Cerebellum

    D. Pellerin, JL. Méreaux, S. Boluda, MC. Danzi, MJ. Dicaire, CS. Davoine, P. Iruzubieta, B. Hayward, D. Genis, G. Spurdens, JM. Hammond, BJ. Gerhart, M. Renaud, C. Bonnet, JS. Napierala, IW. Deveson, M. Napierala, K. Usdin, A. Brice, LM. Porcel, D. Seilhean, SL. Zuchner, H. Houlden, A. Durr, B. Brais (London, United Kingdom)

    Objective: To characterize somatic instability and molecular mechanisms of the FGF14 GAA•TTC repeat across serial blood samples, fibroblasts, induced pluripotent stem cells (iPSCs), and post-mortem brains. Background: Spinocerebellar…
  • 2025 International Congress

    Clinical Progression and Biomarkers in Spinocerebellar Ataxia Type 31, A Form Unique to and Common in Japanese.

    H. Aoki, K. Ishikawa (Tokyo, Japan)

    Objective: The objective of this study is to find a useful clinical marker that reflect progression of spinocerebellar ataxia type 31 (SCA31). Background: SCA31 is…
  • 2025 International Congress

    Response Inhibition and Cortical Excitability in selected SCA subtypes in an Indian Cohort

    S. Majumdar, S. Banerjee, S. Choudhury, S. Sarkar, A. Bayen, J. Ganguly, H. Kumar (Kolkata, India)

    Objective: This study examined response inhibition deficits using the Stop-Signal Reaction Time (SSRT) paradigm in different Spinocerebellar Ataxia (SCA) subtypes and explored cortical involvement through…
  • 2025 International Congress

    The Role of Mitochondrial DNA Haplogroups in determining the Age of Onset in Indian SCA2 Patients.

    A. Sonakar, C. Sharma, S. Reza, S. Pandey, M. Srivastava, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: To investigate the contribution of mitochondrial DNA (mtDNA) haplogroups to the age at onset (AO) of Spinocerebellar Ataxia type 2 (SCA2) in Indian patients,…
  • 2025 International Congress

    Three Siblings with Progressive Cerebellar Ataxia Associated with a Rare PRKCG Variant

    P. Avigan, J. Liu, L. Hogan, S. Frank, B. Benitez, L. Luo (Boston, USA)

    Objective: We report three siblings with late-onset, slowly progressive cerebellar ataxia associated with a c.475G>A (p.Gly159Arg) missense variant in the PRKCG gene. Background: Spinocerebellar ataxia type 14…
  • 2025 International Congress

    Clinical and epidemiological characterization of patients with cerebellar ataxia in a reference center in Northeastern Brazil

    V. Chagas, M. Soares, M. Bezerra (Recife, Brazil)

    Objective: To describe the epidemiological and clinical characteristics of patients with cerebellar ataxia in a Movement Disorders outpatient clinic at a public reference center in…
  • 2025 International Congress

    Effects of an Intensive Multidisciplinary Rehabilitation Program on Patients with Spinocerebellar Ataxia

    F. Coimbra, MC. da Cunha, J. Veloso, M. da Cunha, MR. Moreno, E. Mosimann, L. Siciliani, JR. Junior, J. Caetano, CE. Del Rio, C. Couto (Rio de Janeiro, Brazil)

    Objective: To evaluate the effectiveness of an intensive multidisciplinary rehabilitation program in patients with spinocerebellar ataxia. Background: Spinocerebellar ataxias (SCAs) cause significant motor impairment, affecting…
  • 2025 International Congress

    Spinocerebellar Ataxia 17 Presenting with Childhood Seizures and Mesial Temporal Lobe Sclerosis

    E. Levoir, Y. Bronstein, P. Hickey, C. Fong (Los Angeles, USA)

    Objective: To report an unusual phenotype of spinocerebellar ataxia 17 (SCA17) with childhood onset epilepsy evolving into asymmetric motor impairment with features of dystonia and…
  • 2025 International Congress

    Effects of transcutaneous periodic vibratory stimulation on gait and balance function in Spinocerebellar degeneration -a pilot study

    N. Togashi, S. Kubokawa, K. Minemura, K. Tateno, Y. Miyagi, A. Kawanami, K. Hasegawa (Sagamihara, Japan)

    Objective: The aim of this study is to clarify the efficacy of transcutaneous periodic vibrational stimulation(TPVS)on gait and balance function in patients with spinocerebellar degeneration…
  • 1
  • 2
  • 3
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley